BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29494150)

  • 21. Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells.
    Muralidharan-Chari V; Kohan HG; Asimakopoulos AG; Sudha T; Sell S; Kannan K; Boroujerdi M; Davis PJ; Mousa SA
    Oncotarget; 2016 Aug; 7(31):50365-50379. PubMed ID: 27391262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR4/Let-7a Axis Regulates Metastasis and Chemoresistance of Pancreatic Cancer Cells Through Targeting HMGA2.
    Xiao G; Wang X; Yu Y
    Cell Physiol Biochem; 2017; 43(2):840-851. PubMed ID: 28954272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells.
    Jiang PH; Motoo Y; Sawabu N; Minamoto T
    World J Gastroenterol; 2006 Mar; 12(10):1597-602. PubMed ID: 16570353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion.
    Sumiyoshi H; Matsushita A; Nakamura Y; Matsuda Y; Ishiwata T; Naito Z; Uchida E
    Oncol Rep; 2016 Jun; 35(6):3216-26. PubMed ID: 27035235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells.
    Chen YW; Liu JY; Lin ST; Li JM; Huang SH; Chen JY; Wu JY; Kuo CC; Wu CL; Lu YC; Chen YH; Fan CY; Huang PC; Law CH; Lyu PC; Chou HC; Chan HL
    Mol Biosyst; 2011 Nov; 7(11):3065-74. PubMed ID: 21894339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human SMG-1 is involved in gemcitabine-induced primary microRNA-155/BIC up-regulation in human pancreatic cancer PANC-1 cells.
    Xia QS; Ishigaki Y; Zhao X; Shimasaki T; Nakajima H; Nakagawa H; Takegami T; Chen ZH; Motoo Y
    Pancreas; 2011 Jan; 40(1):55-60. PubMed ID: 20871480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient-derived xenograft tumors.
    Dhar D; Raina K; Kumar D; Wempe MF; Bagby SM; Pitts TM; Orlicky DJ; Agarwal C; Messersmith WA; Agarwal R
    Mol Carcinog; 2020 Oct; 59(10):1227-1240. PubMed ID: 32816368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
    Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC
    Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth inhibition of human pancreatic cancer cells by human interferon-beta gene combined with gemcitabine.
    Endou M; Mizuno M; Nagata T; Tsukada K; Nakahara N; Tsuno T; Osawa H; Kuno T; Fujita M; Hatano M; Yoshida J
    Int J Mol Med; 2005 Feb; 15(2):277-83. PubMed ID: 15647844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2.
    Park SH; Sung JH; Chung N
    Mol Cell Biochem; 2014 Sep; 394(1-2):209-15. PubMed ID: 24894821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
    Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
    Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
    Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M
    Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MAP3K10 promotes the proliferation and decreases the sensitivity of pancreatic cancer cells to gemcitabine by upregulating Gli-1 and Gli-2.
    An Y; Cai B; Chen J; Lv N; Yao J; Xue X; Tu M; Tang D; Wei J; Jiang K; Wu J; Li Q; Gao W; Miao Y
    Cancer Lett; 2013 Feb; 329(2):228-35. PubMed ID: 23178452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of gemcitabine and pemetrexed on the proliferation of pancreatic cancer cell lines BXPC-3 and PANC-1 in vitro].
    Zhu ZX; Zhang WM; Jia G; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):149-52. PubMed ID: 20118008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression.
    Tang K; Zhang Z; Bai Z; Ma X; Guo W; Wang Y
    Oncol Rep; 2011 Apr; 25(4):963-70. PubMed ID: 21225236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cells.
    Wu P; Wang X; Ma Y; Xu X; Liu W; Sheng Z; Chen M; Zhou R; Zhang K; Goodin S; Zheng X; Li D
    Bioorg Chem; 2020 Aug; 101():104022. PubMed ID: 32599367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MSX2 overexpression inhibits gemcitabine-induced caspase-3 activity in pancreatic cancer cells.
    Hamada S; Satoh K; Kimura K; Kanno A; Masamune A; Shimosegawa T
    World J Gastroenterol; 2005 Nov; 11(43):6867-70. PubMed ID: 16425399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition.
    Quint K; Tonigold M; Di Fazio P; Montalbano R; Lingelbach S; Rückert F; Alinger B; Ocker M; Neureiter D
    Int J Oncol; 2012 Dec; 41(6):2093-102. PubMed ID: 23026911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel E2F1-EP300-VMP1 Pathway Mediates Gemcitabine-Induced Autophagy in Pancreatic Cancer Cells Carrying Oncogenic KRAS.
    Ropolo A; Catrinacio C; Renna FJ; Boggio V; Orquera T; Gonzalez CD; Vaccaro MI
    Front Endocrinol (Lausanne); 2020; 11():411. PubMed ID: 32655498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR.
    Zhou H; Telonis AG; Jing Y; Xia NL; Biederman L; Jimbo M; Blanco F; Londin E; Brody JR; Rigoutsos I
    Cell Death Dis; 2016 Jul; 7(7):e2294. PubMed ID: 27415424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.